A Clinical Pharmacological Study to Evaluate the Effects of Iron Supplements on the Pharmacokinetics of MT-6548 in Healthy Male Volunteers
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2018
Price : $35 *
At a glance
- Drugs Vadadustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics; Registrational
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 24 Oct 2018 Status changed from recruiting to completed.
- 12 Sep 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 New trial record